Tuberculosis in hematopoietic stem cell transplant recipients

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 5, Issue 1, 2013, Pages

  Ramos, Jéssica Fernandes ^a   Batista, Marjorie Vieira ^a   Costa, Silvia Figueiredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSPORIN; ETHAMBUTOL; ETHAMBUTOL PLUS ISONIAZID PLUS PYRAZINAMIDE PLUS RIFAMPICIN; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE;

ACID FAST BACTERIUM; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIUM CULTURE; CHEMOTHERAPY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; GRAFT RECIPIENT; HISTOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LATENT TUBERCULOSIS; MOLECULAR DIAGNOSIS; MORTALITY; MYCOBACTERIUM TUBERCULOSIS TEST KIT; POLYMERASE CHAIN REACTION; SYMPTOMATOLOGY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 84906264354     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/mjhid.2013.061     Document Type: Article

References (66)

1. Navari RM, Sullivan, KM, Springmeyer SC, et al. Mycobacterial infections in marrow transplant patients. Transplantation 1983;36(5):509-13. http://dx.doi.org/10.1097/00007890-198311000-00008 PMid:6356515
2. Akan H, Arslan O, Akan OA. Tuberculosis in stem cell transplant patients. J Hosp Infect 2006;62(4):421-6. http://dx.doi.org/10.1016/j.jhin.2005.09.020 PMid:16413085
3. Roy V, Weisdorf D. Mycobacterial infections following bone marrow transplantation: a 20 year retrospective review. Bone Marrow Transplant 1997;19(5):467-0. http://dx.doi.org/10.1038/sj.bmt.1700686 PMid:9052913
4. Keung YK, Nugent K, Jumper C, Cobos E. Mycobacterium tuberculosis infection masquerading as diffuse alveolar hemorrhage after autologous stem cell transplant. Bone Marrow Transplant 1999;23(7):737-8. http://dx.doi.org/10.1038/sj.bmt.1701648 PMid:10218854
5. Kurzrock R, Zander A, Vellekoop L, Kanojia M, Luna, M, Dicke K. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 1984;77(1):35-40. http://dx.doi.org/10.1016/0002-9343 (84)90432-7
6. de la Câmara R, Martino R, Granados E, et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000;26(3):291-8. http://dx.doi.org/10.1038/sj.bmt.1702506 PMid:10967568
7. Budak-Alpdogan T, Tangün Y, Kalayoglu-Besisik S, et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant 2000;6(4):370-4. http://dx.doi.org/10.1016/S1083-8791(00)70013-9
8. Ip MS, Yuen KY, Woo PC, et al. Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 1998;158(4):1173-7. http://dx.doi.org/10.1164/ajrccm.158.4.9712072 PMid:9769278
9. Ku SC, Tang JL, Hsueh PR, Luh KT, Yu CJ, Yang PC. Pulmonary tuberculosis in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27(12):1293-7. http://dx.doi.org/10.1038/sj.bmt.1703092
10. Wang J, Chang Y, Lee L, et al. Diffuse Pulmonary Infiltrates After Bone Marrow Transplantation: The Role of Open Lung Biopsy. Ann Thorac Surg 2004;78:267-72 http://dx.doi.org/10.1016/j.athoracsur.2004.03.002 PMid:15223441
11. Cordonnier C, Martino R, Trabasso P, et al. European Blood and Marrow Transplant Group Infectious Diseases Working Party. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis 2004;38(9):1229-36. http://dx.doi.org/10.1086/383307 PMid:15127333
12. Aljurf M, Gyger M, Alrajhi A, et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant 1999;24(5):551-4 http://dx.doi.org/10.1038/sj.bmt.1701930 PMid:10482941
13. Ullah, K., Ahmed, P., Raza, S., et al. (2007). Allogeneic stem cell transplantation in hematological disorders: single center experience from Pakistan. Transplant Proc;39(10):3347-57. http://dx.doi.org/10.1016/j.transproceed.2007.08.099 PMid:18089384
14. Altclas J, Lescano A, Salgueira C, et al. Multidrug-resistant tuberculosis in bone marrow transplant recipient. Transpl Infect Dis 2005;7(1):45-6. http://dx.doi.org/10.1111/j.1399-3062.2005.00083.x PMid:15984950
15. Maeda T, Kusumi E, Kami M, et al. Tokyo Stem Cell Transplant (SCT) Consortium. Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases. Bone Marrow Transplant 2005;35(1):91-7. http://dx.doi.org/10.1038/sj.bmt.1704740 PMid:15516933
16. Khan B, Ahmed P, Ullah K, Hussain CA, Hussain I, Raza S. Frequency of tuberculosis in haematological malignancies and stem cell transplant recipients. J Coll Physicians Surg Pak 2005;15(1):30-3. PMid:15670521
17. Garces Ambrossi G, Jakubowski A, Feinstein MB, Weinstock, DM. Active tuberculosis limited to foreign-born patients after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 2005;36(8):741-3. http://dx.doi.org/10.1038/sj.bmt.1705129 PMid:16113670
18. George B, Mathews V, Srivastava A, Chandy M. Infections among allogeneic bone marrow transplant recipients in India. Bone Marrow Transplant 2004;33(3):311-15 http://dx.doi.org/10.1038/sj.bmt.1704347 PMid:14647246
19. Lee J, Lee MH, Kim WS, et al. Tuberculosis in hematopoietic stem cell transplant recipients in Korea. Int J Hematol 2004;79(2):185-8. http://dx.doi.org/10.1532/IJH97.A10219 PMid:15005349
20. Erdstein AA, Daas P, Bradstock KF, Robinson T, Hertzberg MS. Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century. Transpl Infect Dis 2004;6(4):142-6. http://dx.doi.org/10.1111/j.1399-3062.2004.00068.x PMid:15762931
21. Yoo JH, Lee DG, Choi SM, et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplant 2004;34(6):497-504. http://dx.doi.org/10.1038/sj.bmt.1704636 PMid:15286689
22. Kerridge I, Ethell M, Potter M, Prentice HG. Mycobacterium tuberculosis infection following allogeneic peripheral blood stem cell transplantation. Intern Med J 2003;33(12):619-20. http://dx.doi.org/10.1111/j.1445-5994.2003.00451.x PMid:14656242
23. Kindler T, Schindel C, Brass U, Fischer T. Fatal sepsis due to Mycobacterium tuberculosis after allogeneic bone marrow transplantation. Bone Marrow Transplantation 2001, 27, 217-18 http://dx.doi.org/10.1038/sj.bmt.1702737 PMid:11281394
24. Campos A, Vaz CP, Campilho F, et al. Central nervous system (CNS) tuberculosis following allogeneic stem cell transplantation. Bone Marrow Transplant 2000;25(5):567-9. http://dx.doi.org/10.1038/sj.bmt.1702163 PMid:10713637
25. Ullah K, Raza S, Ahmed P, et al. Post-transplant infections: single center experience from the developing world. Int J infect Dis 2008;12:203-14. http://dx.doi.org/10.1016/j.ijid.2007.06.012 PMid:17920999
26. Machado CM, Martins TC, Colturato I, et al. Epidemiology of neglected tropical diseases in transplant recipients. Review of the literature and experience of a Brazilian HSCT center. Rev Inst Med Trop Sao Paulo. 2009;51(6):309-24. PMid:20209266
27. Russo RL, Dulley FL, Suganuma L, et al. Tuberculosis in hematopoietic stem cell transplant patients: case report and review of the literature. Int J Infect Dis. 2010;14 Suppl 3:e187-91. http://dx.doi.org/10.1016/j.ijid.2009.08.001 PMid:19819176
28. Kuan FC, Lin PY, Hwang CE, et al. Pancytopenia and myeloid maturation arrest in an autologous stem cell transplant recipient. Bone Marrow Transplant.2011;46(4):610-1. http://dx.doi.org/10.1038/bmt.2010.155 PMid:20622905
29. Rouleau M, Senik A, Leroy E, Vernant JP. Long-term persistence of transferred PPD-reactive T cells after allogeneic bone marrow transplantation. Transplantation 1993;55(1):72-6. http://dx.doi.org/10.1097/00007890-199301000-00014 PMid:8380510
30. Ahmed P, Anwar M, Khan B, et al. Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients. J Pak Med Assoc 2005;55(9):378-81. PMid:16302471
31. Gauchon A, André N, Rome A, et al. Evaluation of a screening strategy after occurence of two simultaneous contaminating tuberculosis cases in a pediatric oncology department. Arch Pediatr 2008;15(3):236-44. http://dx.doi.org/10.1016/j.arcped.2008.01.005 PMid:18329257
32. Tavil B, Gulhan B, Ozcelik U, et al. Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey. Pediatr Transplant 2007, (4):414-18. http://dx.doi.org/10.1111/j.1399-3046.2007.00679.x PMid:17493222
33. Moon SM, Lee SO, Choi SH, Kim YS, Woo JH, Yoon DH, Suh C, Kim DY, Lee JH, Lee JH, Lee KH, Kim SH. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation. Transpl Infect Dis. 2013;15(1):104-9. http://dx.doi.org/10.1111/j.1399-3062.2012.00765.x PMid:22823749
34. Keung YK, Nugent K, Jumper C, et al. Mycobacterium tuberculosis infection masquerading as diffuse alveolar hemorrhage after autologous stem cell trans- plant. Bone Marrow Transplant 1999;23(7):737-35. http://dx.doi.org/10.1038/sj.bmt.1701648 PMid:10218854
35. Friedrich W, O'Reilly RJ, Koziner B, et al. T-lymphocyte reconstitution in recipients of bone marrow transplants with or without GVHD: imbalances on T-cell subpopulation having unique regulatory and cognitive function. Blood 1982; 59: 696-701. PMid:6800422
36. Lum LG, Seigneuret MC, Orcutt-Thordarson N, et al. The regulation of immunoglobulin synthesis after HLA identical bone marrow transplantation. Blood 1985; 65: 1422-1433. PMid:2986745
37. Al-Anazi KA, Al-Jasser AM, Evans DA. Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study. Ann Clin Microbiol Antimicrob. 2007 16;6:16.
38. Jung JI, Lee DG, Kim YJ et al. Pulmonary tuberculosis after hematopoietic stem cell transplantation: radiologic findings. J Thorac Imag. 2009;24(1):10-6. http://dx.doi.org/10.1097/RTI.0b013e31818c6b97 PMid:19242297
39. Delogu G and Herrmann J-L. Mycobacterium species. In European Manual of Clinical Microbiology. 1st edition. ISBN: 978-2-87805-026-4, pages 297-307, 2012.
40. Yamazaki R, Mori T, Nakazato T, Okamoto S et al. Non- Tuberculous Mycobacterial Infection Localized in Small Intestine Developing after Allogeneic Bone Marrow Transplantation. Inter Med 49: 1191-1193, 2010 http://dx.doi.org/10.2169/internalmedicine.49.3288 PMid:20558941
41. Shi JM, Cai Z, Huang H, Ling MF et al. Role of CT-guided percutaneous lung biopsy in diagnosis of pulmonary fungal infection in patients with hematologic diseases. Int J Hematol (2009) 89:624-627 http://dx.doi.org/10.1007/s12185-009-0351-0 PMid:19468797
42. Redelman-Sidi G and Sepkowitz KA. Interferon Gamma Release Assays in the Diagnosis of Latent Tuberculosis Infection Among Immunocompromised Adults. Am J Respir Crit Care Med. 2013. First published online doi: 10.1164/rccm/201209-1621CI.
43. Pai M, Palamountain K M. New tuberculosis technologies: challenges for retooling and scale-up. Int J Tuberc Lung Dis 16 (10): 1281-1290; 2012. 44.
44. MMWR. Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis. January 16, 2009/58 (01); 7-10.
45. Lee J I, Lee BJ, Roy EY et al. The diagnostic accuracy of tuberculosis real-time polymerase chain reaction analysis of computed tomography-guided bronchial wash samples. Diagn Microb Infec Dis 2011; 71: 51-6 http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.019 PMid:21795005
46. Min J-W, Yoon HI, Park KU et al. Real-time polymerase chain reaction in bronchial aspirate for rapid detection of sputum smear-negative tuberculosis. Int J Tuberc Lung Dis 2010; 14(7): 852-8 PMid:20550768
47. Abubakar I, Griffiths C and Ormerod P. Diagnosis of active and latent tuberculosis: summary of NICE guidance. BMJ 2012;345:e6828. http://dx.doi.org/10.1136/bmj.e6828
48. Horne DJ, Narita M, Spitters CL et al. Challenging Issues in Tuberculosis in Solid Organ Transplantation. Clin Infect Dis 2013. http://dx.doi.org/10.1093/cid/cit488
49. Lawn SD, Mwaba P, Bates M et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13: 349-61. http://dx.doi.org/10.1016/S1473-3099(13)70008-2
50. Rajpal S, Kashyap RS, Nayak AR et al. Laboratory Investigations on the Diagnosis of Tuberculosis in the Malnourished Tribal Population of Melghat, India. Plos One 2013, 8 (9): e74652 http://dx.doi.org/10.1371/journal.pone.0074652 PMid:24069327 PMCid:PMC3772098
51. Dubey A, Gwal R, Agrawal S. Mycobacterium tuberculosis detection in blood using multiplex nested polymerase chain reaction. Int J Tuberc Lung Dis. 2013 17 (10):1341-5. http://dx.doi.org/10.5588/ijtld.12.0536 PMid:24025388
52. Bento J, Silva AS, Rodrigues F, Duarte R. Métodos Diagnósticos em Tuberculose. Acta Med Port 2011; 24: 145-154 PMid:21672452
53. Hopewell PC, Pai M, Maher D et al. International standards for tuberculosis care. Lancet Infect Dis. 2006;6 (11):710 http://dx.doi.org/10.1016/S1473-3099 (06)70628-4
54. Yew WW, Lange C and Leung CC. Treament of tuberculosis: update 2010. Eur Respir J 2011; 37: 441-462. http://dx.doi.org/10.1183/09031936.00033010 PMid:20847074
55. World Health Organization. Treatment of Tuberculosis Guidelines; 2009. Report No.: WHO/HTM/TB/2009/420. ISBN: 9789241547833.
56. American Thoracic Society: CDC; Council of the Infectious Disease Society of America. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95 http://dx.doi.org/10.1164/ajrccm.161.4.16141 PMid:10764337
57. Ministério da Saúde do Brasil. Available in http://portal.saude.gov.br/portal/arquivos/pdf/nota_tecnica_versa o_28_de_agosto_v_5.pdf
58. La Camara R, Martino R, Granados E et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Bone Marrow Transplantation (2000) 26, 291-298 http://dx.doi.org/10.1038/sj.bmt.1702506 PMid:10967568
59. Maeda T, Kusumi E, Kami M et al. Disseminated tuberculosis following reduced-intensity cord blood transplantation for adult patients with hematological diseases. Bone Marrow Transplantation (2005) 35, 91-97. http://dx.doi.org/10.1038/sj.bmt.1704740 PMid:15516933
60. De Assis RA, Kerbauy FR, Rodrigues M et al. Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT. Bone Marrow Transplantation (2009) 43, 667-668 http://dx.doi.org/10.1038/bmt.2008.379 PMid:19029968
61. Aguado JM, Torre-Cisneros J, Munoz P et al. Tuberculosis in Solid-Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis 2009; 48:1276-84 http://dx.doi.org/10.1086/597590 PMid:19320593
62. Saukkonen JJ, Cohn DL, Jasmer RM et al. ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med 2006;174:935-952. http://dx.doi.org/10.1164/rccm.200510-1666ST PMid:17021358
63. Devarbhavi H. Adaptation and Antituberculosis Drug-induced Liver Injury. Am J Respir Crit Car Med 2012; 186:387-388. http://dx.doi.org/10.1164/ajrccm.186.4.387 PMid:22896595
64. Altclas J, Lescano A, Palmero D et al. Multidrug-resistant tuberculosis in bone marrow transplant recipient. Transpl Infect Dis 2005: 7: 45-46. http://dx.doi.org/10.1111/j.1399-3062.2005.00083.x PMid:15984950
65. Lienhardt C, Raviglione M, Spigelman M et al. New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future. J Infect Dis 2012; 205:S241-9. http://dx.doi.org/10.1093/infdis/jis034 PMid:22448022
66. Uhlin M, Andersson J, Zumla A and Maeurer M. Adjunct Immunotherapies for Tuberculosis. J Infec Dis 2012; 205: S325-34. http://dx.doi.org/10.1093/infdis/jis197 PMid:22457298